Notably, during IPF progression, these genes especially MTRR, showed decreased expression specifically in AT2 cells, while maintaining stable expression levels in other cell types, thereby establishing AT2 cells as key regulators of Hcy metabolism. The gene discussed is MTRR; the disease is idiopathic pulmonary fibrosis.